Lung cancer treatment puzzle: which drug works best for a rare mutation?
Disease control
Not yet recruiting
This study aims to find out which type of targeted drug works better as the first treatment for advanced lung cancer with a specific, less common genetic change called an EGFR '19delins' mutation. It will compare older 'first-generation' drugs with newer 'third-generation' drugs.…
Phase: EARLY_PHASE1 • Sponsor: Fuzhou General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC